Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
Topics & Concepts
Drug repositioningMedicineDrugPharmacologyBreast cancerAldose reductaseCancerChemotherapySorafenibAldose reductase inhibitorCancer researchInternal medicineOncologyEndocrinologyDiabetes mellitusHepatocellular carcinomaAldose Reductase and TaurineHeme Oxygenase-1 and Carbon MonoxidePrenatal Substance Exposure Effects